NewGenIvf Group (NIVF) Stock Price, News & Analysis

Company Overview

NewGenIvf Group (NASDAQ: NIVF) is a China-based platform specializing in assisted reproductive services and technologies. The company offers a comprehensive suite of fertility solutions, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), pre-implantation genetic testing (PGT), egg and sperm freezing, and donor matching. Through its network of in-house laboratories and outpatient clinics, NewGenIvf seeks to enhance patient outcomes and reduce the time to pregnancy by integrating advanced diagnostic tools, personalized treatment protocols, and data-driven monitoring systems.

Since its founding in 2020, NewGenIvf has expanded rapidly across Mainland China, establishing over 80 fertility centers in more than 40 cities. Each clinic features dedicated embryology labs staffed by certified embryologists, while clinical teams include reproductive endocrinologists, obstetricians, and genetic counselors. The company also leverages partnerships with regional hospitals and women’s health groups to extend its reach into underserved markets and foster collaborative research on novel fertility therapies.

NewGenIvf’s technology platform integrates electronic medical records, patient portal access, and telehealth consultations, enabling prospective parents to receive remote guidance, track treatment milestones, and access educational resources. The company has invested in artificial intelligence tools to analyze historical patient data for optimized stimulation protocols. Additionally, NewGenIvf conducts analytical studies on genetic screening outcomes to refine PGT accuracy and improve embryo selection methodologies.

Led by Chairman and CEO Dr. Yongliang Liu, a former reproductive endocrinologist with over two decades of clinical experience, NewGenIvf combines scientific expertise with an entrepreneurial approach to healthcare delivery. The leadership team includes Chief Medical Officer Dr. Xinru Wang and Chief Operating Officer Ms. Lijuan Chen, both of whom bring extensive backgrounds in clinical operations and patient services. As China’s fertility market continues to evolve under supportive demographic policies, NewGenIvf aims to solidify its position as a leading service provider and innovation partner in reproductive medicine.

Key Stats

• Today's Range: $0.55 to $0.61
• 50-Day Range: $0.56 to $3.70
• 52-Week Range: $0.55 to $656.00
• Volume: 728,196 shs
• Average Volume: 1.06 million shs
• Market Capitalization: $2.40 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NIVF Stock Analysis - Frequently Asked Questions

How have NIVF shares performed this year?

NewGenIvf Group's stock was trading at $81.00 at the beginning of 2025. Since then, NIVF shares have decreased by 99.2% and is now trading at $0.6080.

When did NewGenIvf Group's stock split?

NewGenIvf Group shares reverse split on Tuesday, February 11th 2025.The 1-20 reverse split was announced on Friday, January 31st 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, February 10th 2025. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of NewGenIvf Group?

Shares of NIVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of NewGenIvf Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NewGenIvf Group investors own include Tesla (TSLA), SoFi Technologies (SOFI), Snap (SNAP), Rumble (RUM), Proterra (PTRA), Meta Platforms (META) and Amesite (AMST).

Company Calendar

• Today: 7/18/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:NIVF
• Previous Symbol: NASDAQ:NIVF
• CIK: 1981662
• Web: N/A
• Phone: 65-6818-5796
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.17
• Quick Ratio: 1.14

Sales & Book Value

• Annual Sales: $5.43 million
• Price / Sales: 0.48
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($29.20) per share
• Price / Book: -0.02

Miscellaneous

• Outstanding Shares: 4,320,000
• Free Float: 2,950,000
• Market Cap: $2.63 million
• Optionable: N/A
• Beta: -0.03